Clinical Trial VICCHN0529

Title

Novel Protein Regulator of Tumor Suppressor ARF & NF-kB (NIH/2 R01 DEO13173-05) (deidentified)

Principal Investigator(s)

Wendell Yarbrough

Details

  • Protocol No. VICCHN0529
  • Open Date: 05/10/2005
  • Staging: NA
  • Age Group: Adults
  • Scope: Local
  • Objective:
  • Disease Sites: Head/Neck
  • Therapies: Correlative
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University; Veterans Administration
  • National Clinical Trial ID: NCT00896948
  • Secondary Protocol No: Not Specified

Description

Eligibility

Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.